Abhi Acharya's profile

Abhi Acharya

Principal Investigator

Axilea LLC

I'm working on

7 months ago

Immunotherapy biomaterials, cell therapies, drug delivery

About

Inventor and NSF STTR Phase I awardee developing metabolite-based polymers and particles to support immune-cell therapies. IP covers polymer-enabled immunotherapy; current work advances metabolically fit CAR macrophage platforms with reduced toxicity.

Partnering listings

Learn more

Axilea LLC

Microparticle-based vaccines for spray, oral, and in ovo administration

Axilea LLC offers innovative microparticle-based vaccines that can be administered via spray, oral, or in ovo methods. These vaccines are easy to mass produce, environmentally friendly, and do not require cold storage, m...

TechnologyIn developmentCompany

Abhi Acharya

Principal Investigator

Axilea LLC

Work experience

Case Western Reserve University

Principal Investigator

2023 - Present

Axilea LLC

Principal Investigator

2020 - Present

Top industry applications